Abstract
Beta (β) Thalassemia is a common globin gene disorder in India. Although about 65 different mutations are known in the multiethnic populations of India, the group of 9 ‘core mutations’, i.e. IVSI,5 (G > C){HBB:c.925G > C}, 619 base pair deletion(bp del){NG_000007.3:g.71609_72227del619}, FS8/9 (G){HBB:c.27_28insG}, IVSI,1 (G > T) {HBB:c.92G > T}, FS41/42 (-CTTT){HBB:c.124_127del-CTTT}, C15 (G > A){HBB:c.47G > A}, FS16 (-C){HBB:c.51delC}, C30 (G > C){HBB:c.93G > C} and C5 (-CT){HBB:c17_18delCT} cover about 96% of mutations in the carriers. We attempted a multiplex PCR to detect these mutations using ARMS method and strategized it in high risk groups of western India. The system was found reliable, cost effective, fast and most applicable for mutation screening of β Thalassemia in Indian populations.
Keywords: ARMS PCR, β Thalassemia, DNA diagnostic method, genetic screening, hemoglobinopathies, high risk populations, India, Indian subcontinent, Maharashtra, multiplex PCR, mutations, prenatal diagnosis, South Asian countries, western India
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: Experience with Multiplex ARMS (MARMS)-PCR for the Detection of Common βThalassemia Mutations in India
Volume: 10 Issue: 1
Author(s): Chitra Thakur (Mahadik)
Affiliation:
Keywords: ARMS PCR, β Thalassemia, DNA diagnostic method, genetic screening, hemoglobinopathies, high risk populations, India, Indian subcontinent, Maharashtra, multiplex PCR, mutations, prenatal diagnosis, South Asian countries, western India
Abstract: Beta (β) Thalassemia is a common globin gene disorder in India. Although about 65 different mutations are known in the multiethnic populations of India, the group of 9 ‘core mutations’, i.e. IVSI,5 (G > C){HBB:c.925G > C}, 619 base pair deletion(bp del){NG_000007.3:g.71609_72227del619}, FS8/9 (G){HBB:c.27_28insG}, IVSI,1 (G > T) {HBB:c.92G > T}, FS41/42 (-CTTT){HBB:c.124_127del-CTTT}, C15 (G > A){HBB:c.47G > A}, FS16 (-C){HBB:c.51delC}, C30 (G > C){HBB:c.93G > C} and C5 (-CT){HBB:c17_18delCT} cover about 96% of mutations in the carriers. We attempted a multiplex PCR to detect these mutations using ARMS method and strategized it in high risk groups of western India. The system was found reliable, cost effective, fast and most applicable for mutation screening of β Thalassemia in Indian populations.
Export Options
About this article
Cite this article as:
Thakur (Mahadik) Chitra, Experience with Multiplex ARMS (MARMS)-PCR for the Detection of Common βThalassemia Mutations in India, Cardiovascular & Hematological Agents in Medicinal Chemistry 2012; 10 (1) . https://dx.doi.org/10.2174/187152512799201208
DOI https://dx.doi.org/10.2174/187152512799201208 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neonatal Persistent Pulmonary Hypertension Associated with Congenital Cystic Adenomatoid Malformation Treated with Sildenafil: Case Report
Current Pediatric Reviews Natural Polyphenols and Cardioprotection
Mini-Reviews in Medicinal Chemistry Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Strategies and Techniques for Multi-Component Drug Design from Medicinal Herbs and Traditional Chinese Medicine
Current Topics in Medicinal Chemistry Potentials of ES Cell Therapy in Neurodegenerative Diseases
Current Pharmaceutical Design Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke
Cardiovascular & Hematological Disorders-Drug Targets Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions
Current Vascular Pharmacology Low Molecular Weight and Oligomeric Chitosans and Their Bioactivities
Current Topics in Medicinal Chemistry Heme Oxygenase-1 in Lung Disease
Current Drug Targets Anti-Aging Drugs – Prospect of Longer Life?
Current Medicinal Chemistry Ivabradine: A Current Overview
Current Clinical Pharmacology Subcellular Analysis of the Platelet Proteome
Current Proteomics Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design In vitro and In silico: Selectivities of Seychellene Compound as Candidate Cyclooxygenase Isoenzyme Inhibitor on Pre-Osteoblast Cells
Current Enzyme Inhibition Targeting the Metabotropic Glutamate Receptor mGluR4 for the Treatment of Diseases of the Central Nervous System
Current Topics in Medicinal Chemistry DNA and RNA Aptamers as Modulators of Protein Function
Medicinal Chemistry Nutrigenetics of the Postprandial Lipoprotein Metabolism: Evidences From Human Intervention Studies
Current Vascular Pharmacology Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides
Cardiovascular & Hematological Agents in Medicinal Chemistry HDL-Related Mechanisms of Olive Oil Protection in Cardiovascular Disease
Current Vascular Pharmacology Potential Application of Centrifuges to Protect the CNS in Space and on Earth
Current Alzheimer Research